How much does the genuine Sotoraxibu cost?

Sotorasib is a new anti-cancer drug that belongs to the KRAS G12C inhibitor class. KRAS G12C is a Kirsten Rat Sarcoma Viral Oncogene Homolog mutant form, which plays a key role in cell signaling. Sotoracib is unique in that it specifically targets the KRAS G12C mutation that is prevalent in patients with non-small cell lung cancer (NSCLC).

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.

This drug works by blocking the activity of the KRAS G12C variant, thereby slowing or inhibiting the growth and spread of cancer cells. For patients with NSCLC whose KRAS G12C mutation makes it difficult to treat, sotorasib provides a new treatment option. Because KRAS mutants are found in a variety of cancers, including colorectal cancer, the research and development of sotorasiib may also play an important role in future treatments involving other cancer types.

Clinical studies of sotoraxib show that in some patients, the drug shows encouraging anti-cancer effects. However, like all medications, sotoraxib can cause a range of side effects, so patients' health needs to be closely monitored during use. Patients should work closely with their doctor when receiving this treatment, undergo regular check-ups, and receive treatment according to their doctor's recommendations.